Newmont supplements proxy for Newcrest deal, resolves shareholder lawsuits

NEWMONT Corp /DE/

Two federal class actions filed Sept. 20-21, 2023 alleged proxy omissions; Newmont voluntarily supplements.
Plaintiffs agree to dismiss claims as moot in exchange for supplemental disclosures; Newmont denies liability.
BofA DCF: Newcrest standalone equity value $13.91-$16.32/shr (ex-synergies); Newmont $31.71-$37.29/shr.
Centerview used real discount rates 5.75%-7.75% for Newcrest, 5.0%-7.0% for Newmont in DCF analyses.
Supplement discloses Newcrest net debt ~$2.8B (incl. $1B special dividend) and Newmont net debt ~$2.4B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.